Fortaleza Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-3,180
| Closed | -$138K | – | 168 |
|
|
2017
Q1 | $138K | Sell |
3,180
-85
| -3% | -$3.69K | 0.28% | 113 |
|
|
2016
Q4 | $126K | Hold |
3,265
| – | – | 0.27% | 114 |
|
|
2016
Q3 | $165K | Buy |
3,265
+85
| +3% | +$4.3K | 0.23% | 79 |
|
|
2016
Q2 | $145K | Sell |
3,180
-1,620
| -34% | -$73.9K | 0.12% | 85 |
|
|
2016
Q1 | $190K | Hold |
4,800
| – | – | 0.12% | 93 |
|
|
2015
Q4 | $272K | Sell |
4,800
-120
| -2% | -$6.8K | 0.16% | 73 |
|
|
2015
Q3 | $196K | Sell |
4,920
-1,800
| -27% | -$71.7K | 0.14% | 105 |
|
|
2015
Q2 | $321K | Buy |
6,720
+3,070
| +84% | +$147K | 0.19% | 93 |
|
|
2015
Q1 | $145K | Buy |
+3,650
| New | +$145K | 0.08% | 156 |
|